Immutep shares gain as CapitalOne sets $10 target on cancer drug potential By Investing.com
On Friday, Immutep Limited (NASDAQ:) received a positive assessment from CapitalOne, as the firm initiated coverage with an Overweight rating ...
On Friday, Immutep Limited (NASDAQ:) received a positive assessment from CapitalOne, as the firm initiated coverage with an Overweight rating ...
© Reuters. Fortinet shares slide as CapitalOne downgrades stock on more challenging first half Fortinet (NASDAQ:) shares fell more than ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.